Introduction {#sec0001}
============

In 2019, the first cases of COVID-19 pneumonia and acute respiratory distress syndrome were reported in China [@bib0001]. The virus quickly propagated with the first case in the United States reported in January 2020 [@bib0001]. Since its discovery, there has been scientific pressure to characterize the symptomatology caused by the SARS CoV-2 virus. Common symptoms in pediatric populations include fever (36%-80%), dry cough (19%-65%), tachycardia (42%), tachypnea (29%), and less commonly diarrhea, vomiting, and abdominal pain (4%-10%) [@bib0002]. A majority of pediatric patients presenting with SARS CoV-2 present with mild symptoms (51%) including acute URI, fever, fatigue, myalgia, nausea, vomiting, abdominal pain and diarrhea [@bib0003]. As of March 5, 2020, the CDC reports only 2% of confirmed SARS CoV-2 cases in the United States have occurred in patients \<18 years old [@bib0004].

Acute pancreatitis in children occurs in approximately 1/10,000 children per year [@bib0005]. Viral infections are identified as a cause of acute pancreatitis in approximately 8%-10% of cases in children with other common causes being biliary/obstructive (10%-30%), medications (5%-25%), and trauma (10%-20%) [@bib0005].

Case report {#sec0002}
===========

We present a case of a previously well 7-year-old girl who initially complained of 48 hours of abdominal pain and anorexia. She was afebrile, with elevated lipase (676, normal 80-360 U/L) and an abdominal ultrasound and CT ([Figs. 1](#fig0001){ref-type="fig"} and [2](#fig0002){ref-type="fig"}) suggestive of necrotizing pancreatitis. The lower chest on the abdominal CT showed a normal-sized heart, small bilateral pleural effusions, and clear lung bases. Her pancreatitis was managed with IV fluids, ketorolac, and hydralazine; she was started on ceftriaxone and metronidazole. She improved with supportive care and was discharged on hospital day 4 with a normal lipase. Two weeks later her abdominal pain returned and was associated with reported fever (101°F).Fig. 1Midline transverse grayscale sonographic image at the level of the pancreas (black arrows) reveals diffuse pancreatic enlargement and heterogeneous pancreatic echogenicity (white arrow) concerning for acute pancreatitis.Fig 1Fig. 2Postcontrast axial CT image at the level of the pancreas (black arrows) reveals diffuse pancreatic edema/enlargement with peripancreatic fluid and increased attenuation of the adjacent peripancreatic fat representing acute pancreatitis. An area of pancreatic parenchymal hypoenhancement (white arrow) is suspicious for pancreatic necrosis (necrotizing pancreatitis).Fig 2

Simultaneously, her mother, a warehouse worker was experiencing fever, cough, and shortness of breath. Our patient denied shortness of breath or cough. She also presented with nonbloody, nonbilious emesis left lower quadrant, and epigastric pain.

On examination, her vital signs were BP: 130/92, P: 128, T: 99.9°F, RR: 24, BMI 13.79. She appeared uncomfortable, but nontoxic. Her abdominal exam was significant for distension and tenderness to palpation in the left upper and left lower quadrant, and the epigastric regions. There was fullness noted in the left upper, but no splenic edge was felt and there was no guarding, rebound, right lower quadrant tenderness, Rovsing, or psoas sign.

Her lipase this time was 1672 U/L, and due to fever and potential family exposure in a COVID-19 pandemic she was tested for SARS CoV-2 by polymerase chain reaction which was positive. She had thrombocytosis (498 thou/cmm), an elevated LDH (271 U/L), and an elevated IL-6 (13 pg/mL). A complete respiratory viral panel was negative including influenza A, B and RSV. She was managed again with bowel rest, IV, ketorolac, acetaminophen, and ceftriaxone and metronidazole until blood cultures returned. Over the next 2 days, she improved significantly and was discharged with a lipase that was trending down. Of note, the patient\'s mother, her mother\'s partner, and her older sister all tested positive for COVID-19 after the patient.

Discussion {#sec0003}
==========

While there is evidence that children with COVID-19 develop abdominal pain and vomiting, the effects of the virus specifically on the pancreas have not been described \[[@bib0002],[@bib0003],[@bib0006],[@bib0007]\]. It is unclear if our patient\'s pancreatitis was associated or caused by COVID-19. Because children remain PCR positive longer than adults and they do not have to show respiratory symptoms, patients can have the disease for long before symptoms; it is possible that even the first experience of pancreatitis was related to COVID-19 [@bib0002]. In hindsight, her initial CT showed not only mild-to-moderate edema and ascites in the abdomen and pelvis but also small bilateral pleural effusions. Her lipase on the second admission was much higher---there is at the least, concern that there may have been a new factor that aggravated her underlying necrotizing pancreatitis. The mechanism for how COVID-19 infection can cause acute pancreatitis is unclear. It may be related to direct infection of the pancreas by the virus, as has been reported for other viruses \[[@bib0008],[@bib0009]\]. There is currently some evidence that it enters GI epithelium via ACE-2 receptors, the same receptor it enters in the lungs, which may provide a possible pathophysiologic explanation for GI symptoms experienced in patients. The endothelial location of the ACE-2 receptors is also the hypothesized mechanism for increased thrombophilia in COVID-19 and potentially an etiology of the acute pancreatitis [@bib0010]. This case certainly leaves the possibility of a coincidental nature of COVID-19 and pancreatitis in a child, it was not on the differential for the child in the first hospital stay. Currently, the literature has focused on respiratory symptoms and associated lymphopenia and elevated liver function abnormalities, whereas the GI symptoms are left largely unexplored \[[@bib0002],[@bib0003],[@bib0006],[@bib0007]\]. Further research is needed to explore the possibility of causation for acute pancreatitis in children with COVID-19. In the current pandemic, consideration for SARS CoV-2 testing in children with acute pancreatitis may be considered. Finally, this case highlights the need for appropriate personal protective equipment, even when COVID is not initially on the differential.
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